Articles

The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes

Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada
Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada
Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada
IWK Health Centre, Halifax, Nova Scotia, Canada
CancerCare Manitoba, Winnipeg, Manitoba, Canada
British Columbia Children’s Hospital, Vancouver, British Columbia, Canada
Hôpital Ste. Justine, Montréal, Québec, Canada
Queen’s University, Kingston, Ontario, Canada
Princess Margaret Hospital, Toronto, Ontario, Canada
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
Centre Hospital University Quebec-Pav CHUL, Sainte-Foy, Quebec, Canada
Montreal Children’s Hospital, Montreal, Québec, Canada
Alberta Children’s Hospital, Calgary, Alberta, Canada
University of Saskatchewan, Saskatoon, Saskatchewan, Canada
University of Alberta/Health Sciences Centre, Edmonton, Alberta, Canada
McMaster Children’s Hospital/McMaster University Health Sciences Centre, Hamilton, Ontario, Canada
Children’s Hospital of Western Ontario, London, Ontario, Canada
Janeway Child Health Centre, St. John’s, Newfoundland, Canada
The Hospital for Sick Children, Toronto, Ontario, Canada
Division of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
Program in Population Genomics, Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Canada
Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada
Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada
Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada
Vol. 100 No. 5 (2015): May, 2015 https://doi.org/10.3324/haematol.2014.117457